{'fraction_non_alphanumeric': 0.03244274809160305, 'fraction_numerical': 0.009541984732824428, 'mean_word_length': 5.818181818181818, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The association between apolipoprotein A‐1 plasma level and premature coronary artery disease: A systematic review and meta‐analysis

Apolipoprotein A‐1 (Apo A‐1) is a constituent of high‐density lipoprotein (HDL) and emerging evidences put forward a potential association between Apo A‐1 plasma levels and premature coronary artery disease (pCAD). The aim of the present study is to gather relative literature and perform a systematic review and meta‐analysis regarding the association between serum ApoA‐1 levels and pCAD.